Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: Similarities to EBV-positive Hodgkin's lymphoma

Lancet

Volumn 361, Issue 9353, 2003, Pages 217-223

  Timms, Judith M ^a   Bell, Andrew ^a   Flavell, Joanne R ^a   Murray, Paul G ^a   Rickinson, Alan B ^a   Traverse Glehen, Alexandra ^b   Berger, Françoise ^b   Delecluse, Henri Jacques ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; LATENT MEMBRANE PROTEIN 1; VIRUS ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL ASSAY; CELL SURVIVAL; CELLULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENOTYPE; HISTOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; IN VIVO STUDY; LYMPHOPROLIFERATIVE DISEASE; MEMORY CELL; PATHOGENESIS; PHYSIOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION; STEM CELL; TARGET CELL; TRANSPLANTATION; VIRUS TRANSFORMATION;

EID: 0037452195     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12271-4     Document Type: Article

References (29)

1. Rickinson A.B., Kieff E. Epstein-Barr virus. Knipe D.M., Howley P.M. Fields Virology. 4th edn: 2001;2575-2627 Lippincott, Williams and Raven, Philadelphia.
2. Chapman C.J., Mockridge C.I., Rowe M., Rickinson A.B., Stevenson F.K. Analysis of VH genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity. Blood. 85:1995;2176-2181.
3. Tamaru J., Hummel M., Marafioti T., et al. Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations. Am J Pathol. 147:1995;1398-1407.
4. Kuppers R., Rajewsky K., Zhao M., et al. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA. 91:1994;10962-10966.
5. Kanzler H., Kuppers R., Hansmann M.L., Rajewsky K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med. 184:1996;1495-1505.
6. Rajewsky K. Clonal selection and learning in the antibody system. Nature. 381:1996;751-758.
7. Kuppers R., Rajewsky K. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease. Annu Rev Immunol. 16:1998;471-493.
8. Young L., Alfieri C., Hennessy K., et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med. 321:1989;1080-1085.
9. Thomas J.A., Hotchin N.A., Allday M.J., et al. Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation. 49:1990;944-953.
10. Kurth J., Spieker T., Wustrow J., et al. EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. Immunity. 13:2000;485-495.
11. Babcock G.J., Decker L.L., Volk M., Thorley-Lawson D.A. EBV persistence in memory B cells in vivo. Immunity. 9:1998;395-404.
12. Babcock G.J., Hochberg D., Thorley-Lawson A.D. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity. 13:2000;497-506.
13. Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. 2001;IARC Press, Lyon.
14. Delecluse H.J., Kremmer E., Rouault J.P., et al. The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders. Am J Pathol. 146:1995;1113-1120.
15. Aubin J., Davi F., Nguyen-Salomon F., et al. Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia. 9:1995;471-479.
16. Lossos I.S., Tibshirani R., Narasimhan B., Levy R. The inference of antigen selection on Ig genes. J Immunol. 165:2000;5122-5126.
17. Klein U., Goossens T., Fischer M., et al. Somatic hypermutation in normal and transformed human B cells. Immunol Rev. 162:1998;261-280.
18. Hanto D.W., Birkenbach M., Frizzera G., et al. Confirmation of the heterogeneity of posttransplant Epstein-Barr virus-associated B cell proliferations by immunoglobulin gene rearrangement analyses. Transplantation. 47:1989;458-464.
19. Starzl T.E., Nalesnik M.A., Porter K.A., et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet. 1:1984;583-587.
20. Brauninger A., Spieker T., Willenbrock K., et al. Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor deficient) epstein-barr virus-infected b cells in angioblastic t cell lymphoma. J Exp Med. 194:2001;927-940.
21. Cesarman E., Chadburn A., Liu Y.F., et al. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome. Blood. 92:1998;2294-2302.
22. Knowles D.M., Cesarman E., Chadburn A., et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 85:1995;552-565.
23. Levy S., Mendel E., Kon S., Avnur Z., Levy R. Mutational hot spots in Ig V region genes of human follicular lymphomas. J Exp Med. 168:1988;475-489.
24. Pallesen G., Hamilton-Dutoit S.J., Rowe M., Young L.S. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet. 337:1991;320-322.
25. Herbst H., Dallenbach F., Hummel M., et al. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA. 88:1991;4766-4770.
26. Nalesnik M.A., Randhawa P., Demetris A.J., et al. Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient. Cancer. 72:1993;2568-2573.
27. Bierman P.J., Vose J.M., Langnas A.N., et al. Hodgkin's disease following solid organ transplantation. Ann Oncol. 7:1996;265-270.
28. Rowlings P.A., Curtis R.E., Passweg J.R., et al. Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation. J Clin Oncol. 17:1999;3122-3127.
29. Garnier J.L., Lebranchu Y., Dantal J., et al. Hodgkin's disease after transplantation. Transplantation. 61:1996;71-76.